FBP1 and pancreatic neoplasm: Given the importance of the inhibition of cancer progression by FBP1 and the unclear underlying molecular mechanism for this, we performed a drug screening assay in FBP1 knockdown or overexpressing pancreatic cancer cells (PANC-1) and compared the IC50 values of each small molecule with that of the controls (Fig. 1a).